Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
H. Lee Moffitt Cancer Center & Research Institute Inc, Medical Devices Deals, 2011 to YTD 2017 9
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
ITUS Enters into Agreement with Moffitt Cancer Center 12
Helix BioPharma and Moffitt Cancer Center Enter into Agreement 13
Vycellix Enters into Research Agreement with Moffitt Cancer Center 14
Lion Biotechnologies Enters into Research Agreement with H. Lee Moffitt Cancer Center and Research Institute 15
Incyte Enters into Agreement with Moffitt Cancer Center 16
Morphogenesis Enters into Agreement with Moffitt Cancer Center 17
Ignyta Enters into Research Agreement with Moffitt Cancer Center 18
HealthMyne Enters into Research Agreement with Moffitt Cancer Center 19
Lion Biotech Enters into Research Agreement with Lee Moffitt Cancer Center and Research Institute 20
Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 21
Moffitt Cancer Center Enters Into Agreement With Advinus For Target Cancer Therapies 22
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 23
H. Lee Moffitt Cancer Forms Joint Venture With US Oncology Network 24
Licensing Agreements 25
Lion Biotech Enters into Licensing Agreement wih Moffitt Cancer Center 25
Moffitt Cancer Center Enters into Licensing Agreement with Celgene 26
Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 27
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 28
H. Lee Moffitt Cancer Center & Research Institute Inc – Key Competitors 30
H. Lee Moffitt Cancer Center & Research Institute Inc – Key Employees 31
H. Lee Moffitt Cancer Center & Research Institute Inc – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Government and Public Interest 34
Jun 12, 2017: Moffitt researchers identify inhibitor that overcomes drug resistance in prostate cancer 34
Jan 11, 2017: Moffitt researchers develop novel treatment to prevent graft-versus-host-disease 35
Jul 15, 2016: Moffitt Cancer Center Receives Two NCI Grants 36
Jul 08, 2016: Moffitt Researchers Find New Way to Control Genes Often Involved in Cancer Growth 37
May 13, 2016: Genetic biomarker may predict nerve pain side effects associated with prostate cancer treatment 38
Mar 17, 2016: Neutralizing a Tumor’s Acidic Environment Improves Activity of Immune-Targeting Cancer Therapies, Says Moffitt Cancer Center Researchers 39
Product News 40
Oct 12, 2017: 10 SU2C Catalyst Clinical Trials Launched 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Key Facts 2
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
H. Lee Moffitt Cancer Center & Research Institute Inc, Deals By Therapy Area, 2011 to YTD 2017 8
H. Lee Moffitt Cancer Center & Research Institute Inc, Medical Devices Deals, 2011 to YTD 2017 9
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
ITUS Enters into Agreement with Moffitt Cancer Center 12
Helix BioPharma and Moffitt Cancer Center Enter into Agreement 13
Vycellix Enters into Research Agreement with Moffitt Cancer Center 14
Lion Biotechnologies Enters into Research Agreement with H. Lee Moffitt Cancer Center and Research Institute 15
Incyte Enters into Agreement with Moffitt Cancer Center 16
Morphogenesis Enters into Agreement with Moffitt Cancer Center 17
Ignyta Enters into Research Agreement with Moffitt Cancer Center 18
HealthMyne Enters into Research Agreement with Moffitt Cancer Center 19
Lion Biotech Enters into Research Agreement with Lee Moffitt Cancer Center and Research Institute 20
Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 21
Moffitt Cancer Center Enters Into Agreement With Advinus For Target Cancer Therapies 22
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 23
H. Lee Moffitt Cancer Forms Joint Venture With US Oncology Network 24
Lion Biotech Enters into Licensing Agreement wih Moffitt Cancer Center 25
Moffitt Cancer Center Enters into Licensing Agreement with Celgene 26
Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 27
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 28
H. Lee Moffitt Cancer Center & Research Institute Inc, Key Competitors 30
H. Lee Moffitt Cancer Center & Research Institute Inc, Key Employees 31
H. Lee Moffitt Cancer Center & Research Institute Inc, Subsidiaries 33